Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

155.91
+0.56000.36%
Post-market: 155.910.00000.00%16:10 EDT
Volume:5.14M
Turnover:802.55M
Market Cap:375.13B
PE:17.35
High:157.02
Open:155.45
Low:154.29
Close:155.35
Loading ...

The Zacks Analyst Blog Highlights Visa, Johnson & Johnson, Thermo Fisher and AMREP

Zacks
·
19 Mar

Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific

Zacks
·
19 Mar

Johnson & Johnson (NYSE:JNJ) Gains FDA Fast Track For Nipocalimab In Treating Sjogren's Disease

Simply Wall St.
·
19 Mar

Johnson & Johnson Says US FDA Grants Fast Track Designation for Sjogren's Disease Treatment

MT Newswires Live
·
18 Mar

Nipocalimab, the First and Only Investigational Treatment to Be Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults With Moderate-to-Severe SjÖGren's Disease, Has NOW Received Fast Track Designation

THOMSON REUTERS
·
18 Mar

J&J: Actively Enrolling Patients in Phase 3 Daffodil Study

THOMSON REUTERS
·
18 Mar

Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sjögren's disease, has now received Fast Track designation

PR Newswire
·
18 Mar

Protagonist Therapeutics Named to Fast Company's Annual List of the World's Most Innovative Companies of 2025

ACCESS Newswire
·
18 Mar

Jim Cramer Says Johnson & Johnson (JNJ) Stock Could Fall to $160 Level

Insider Monkey
·
18 Mar

STAAR Surgical Announces Realignment of Leadership Structure

Business Wire
·
18 Mar

Johnson & Johnson (JNJ) Rises But Trails Market: What Investors Should Know

Zacks
·
18 Mar

BRIEF-Nanobiotix amends global licensing agreement for JNJ-1900 (NBTXR3)

Reuters
·
18 Mar

Nanobiotix Sa: Amended Agreement Enabled Nanobiotix to Strengthen Financial Position, Extending Cash Visibility to Mid-2026

THOMSON REUTERS
·
18 Mar

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Zacks
·
17 Mar

Johnson & Johnson (JNJ) Could Be a Great Choice

Zacks
·
14 Mar

Big Pharma Walked Away From Mental Health. Why Some Are Coming Back. -- Heard on the Street -- WSJ

Dow Jones
·
14 Mar

Johnson & Johnson (JNJ): “Breakout or Breakdown?” – Jim Cramer Says JNJ Must Fall for Market to Bottom

Insider Monkey
·
14 Mar

FACTBOX-Trump's tariffs and threatened trade actions

Reuters
·
14 Mar

Johnson & Johnson (NYSE:JNJ) Faces Shareholder Activism Over Human Rights and Executive Pay Proposals

Simply Wall St.
·
14 Mar

Johnson & Johnson’s Strategic Shift to Comprehensive Procedural Solutions Drives Buy Rating

TIPRANKS
·
14 Mar